L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis

Status:
Recruiting

Trial end date:
2026-03-05

Target enrollment:

Participant gender:

This study aims at evaluating the possible efficacy and safety of L-carnitine in rheumatoid arthritis via targeting Jak/STAT pathway and TGF-β1

Phase 3

Tanta University